⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Alpha-Ketoglutarate (AKG)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-09 — α-Ketoglutarate Promotes Hepatic Steatosis by Enhancing Cidec Stability via Lactylation-Ubiquitination Crosstalk.: [animal-model] A long-term dietary supplementation study in healthy mice found that AKG induced hepatic steatosis through lactylation–ubiquitination crosstalk that stabilized Cidec and suppressed adipose triglyceride lipase (ATGL) activity; whether this occurs in humans remains unresolved. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
α-Ketoglutarate Promotes Hepatic Steatosis by Enhancing Cidec Stability via Lactylation-Ubiquitination Crosstalk.
09-nov-2026
novelty 3
per-area 3
strengthens